PROFOUND MEDICAL CORP (PROF:NASDAQ)
$7.33 0.07 (0.9642%)
Analysed PROFOUND MEDICAL CORP (PROF:NASDAQ) News Sources
Profound Medical Annual General and Special Meeting of Shareholders Voting Results
14-05-2026
yahoo.com
Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026
14-05-2026
yahoo.com
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
15-05-2026
yahoo.com
Wall Street Analysts See a 59.68% Upside in Profound Medical (PROF): Can the Stock Really Move This High?
18-05-2026
yahoo.com
Profound Medical Corp. (PROF) Dropped Despite High Potential
22-06-2026
yahoo.com
Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?
07-07-2026
yahoo.com
Profound Medical: Autonomous Robotics and Incisionless Surgery to Have Exceptional Presence at SRS2026
15-07-2026
yahoo.com
Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
16-07-2026
yahoo.com
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
24-07-2026
yahoo.com
Sector Update: Healthcare Stocks Higher Late Afternoon
24-07-2026
yahoo.com
What is the current price of PROFOUND MEDICAL CORP (PROF:NASDAQ)?
The current price of PROFOUND MEDICAL CORP (PROF:NASDAQ) is $7.33.
PROFOUND MEDICAL CORP (PROF:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROFOUND MEDICAL CORP (PROF:NASDAQ) since the previous trading day is $0.07.
PROFOUND MEDICAL CORP (PROF:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROFOUND MEDICAL CORP (PROF:NASDAQ) since the previous trading day is 0.9642%.
What is the most recent average sentiment score for PROFOUND MEDICAL CORP (PROF:NASDAQ)?
The most recent average sentiment score for PROFOUND MEDICAL CORP (PROF:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for PROFOUND MEDICAL CORP (PROF:NASDAQ)?
The most recent sentiment for PROFOUND MEDICAL CORP (PROF:NASDAQ) is .
SEC-8K** Filing Available For PROFOUND MEDICAL CORP (PROF:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.